Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0K0OR
|
|||
Former ID |
DNC013508
|
|||
Drug Name |
1-(5-(pyridin-2-yl)oxazol-2-yl)octan-1-one
|
|||
Synonyms |
CHEMBL175021; 1-(5-(pyridin-2-yl)oxazol-2-yl)octan-1-one; SCHEMBL3197441; VLJKBQYNIDBQEJ-UHFFFAOYSA-N; BDBM50163176
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H20N2O2
|
|||
Canonical SMILES |
CCCCCCCC(=O)C1=NC=C(O1)C2=CC=CC=N2
|
|||
InChI |
1S/C16H20N2O2/c1-2-3-4-5-6-10-14(19)16-18-12-15(20-16)13-9-7-8-11-17-13/h7-9,11-12H,2-6,10H2,1H3
|
|||
InChIKey |
VLJKBQYNIDBQEJ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.